Related references
Note: Only part of the references are listed.Tissue-repairing blood-derived macrophages are essential for healing of the injured spinal cord: From skin-activated macrophages to infiltrating blood-derived cells?
Michal Schwartz
BRAIN BEHAVIOR AND IMMUNITY (2010)
Molecular cues guiding inflammatory responses
Olga Barreiro et al.
CARDIOVASCULAR RESEARCH (2010)
Assessing Activation States in Microglia
Carol A. Colton et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
α-Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1
Eun-Jung Lee et al.
JOURNAL OF IMMUNOLOGY (2010)
Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells
So Hyun Joo et al.
NEUROSCIENCE LETTERS (2010)
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Vanesa Sanchez-Guajardo et al.
PLOS ONE (2010)
Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice
Xing-Long Gu et al.
MOLECULAR BRAIN (2010)
Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease
David K. Stone et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Peripheral cytokines profile in Parkinson's disease
M. Reale et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2009)
Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy
Chee Yeun Chung et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
α-Synuclein and neuronal cell death
Mark R. Cookson
MOLECULAR NEURODEGENERATION (2009)
Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
Xiaomin Su et al.
NEUROTOXICITY RESEARCH (2009)
The influence of microglia on the pathogenesis of Parkinson's disease
Caitriona M. Long-Smith et al.
PROGRESS IN NEUROBIOLOGY (2009)
Microglial phagocytosis is enhanced by monomeric α-synuclein, not aggregated α-synuclein:: Implications for Parkinson's disease
Ji-Young Park et al.
GLIA (2008)
Immunological features of alpha-synuclein in Parkinson's disease
Cintia Roodveldt et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
Shaji Theodore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Synuclein activates microglia in a model of Parkinson's disease
Xiaomin Su et al.
NEUROBIOLOGY OF AGING (2008)
α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
Andis Klegeris et al.
NEUROBIOLOGY OF AGING (2008)
Nitrated α-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Eric J. Benner et al.
PLOS ONE (2008)
Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Origins and effects of extracellular alpha-synuclein: Implications in Parkinson's disease
Seung-Jae Lee
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Circulating interleukin-15 and RANTES chemokine in Parkinson's disease
M. Rentzos et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Identification of proteins involved in microglial endocytosis of α-synuclein
Jun Liu et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein
Wei Zhang et al.
GLIA (2007)
Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease
Mark P. Thomas et al.
JOURNAL OF NEUROCHEMISTRY (2007)
α-synuclein expression modulates microglial activation phenotype
Susan A. Austin et al.
JOURNAL OF NEUROSCIENCE (2006)
Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells
Andis Klegeris et al.
FASEB JOURNAL (2006)
Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease
Yoon Seong Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Familial mutants of α-synuclein with increased neurotoxicity have a destabilized conformation
CW Bertoncini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Genetics of Parkinson's disease
T Gasser
CURRENT OPINION IN NEUROLOGY (2005)
Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases
JY Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Intravesicular localization and exocytosis of α-synuclein and its aggregates
HJ Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Molecular pathogenesis of Parkinson disease
JL Eriksen et al.
ARCHIVES OF NEUROLOGY (2005)
Release of long-range tertiary interactions potentiates aggregation of natively unstructured α-synuclein
CW Bertoncini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
Emilie Croisier et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations
MM Dedmon et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
α-Syrtuclein, Parkinson's disease, and Alzheimer's disease
SH Kim et al.
PARKINSONISM & RELATED DISORDERS (2004)
Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis
G Candiano et al.
ELECTROPHORESIS (2004)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms
V Bonifati et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Abnormal migration of human wild-type α-synuclein upon gel electrophoresis
CEH Moussa et al.
NEUROSCIENCE LETTERS (2004)
Could a loss of α-synuclein function put dopaminergic neurons at risk?
RG Perez et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease
S Gangemi et al.
MEDIATORS OF INFLAMMATION (2003)
High-yield isolation of murine microglia by mild trypsinization
J Saura et al.
GLIA (2003)
Dependence of α-synuclein aggregate morphology on solution conditions
W Hoyer et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
Demonstration of α-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment
F Mori et al.
EXPERIMENTAL NEUROLOGY (2002)
IFN-γ-Inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking
JH Dufour et al.
JOURNAL OF IMMUNOLOGY (2002)
Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein
NB Cole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Clinical features of parkinsonian patients with the α-synuclein (G209A) mutation
S Bostantjopoulou et al.
MOVEMENT DISORDERS (2001)
The role of glial cells in Parkinson's disease
M Vila et al.
CURRENT OPINION IN NEUROLOGY (2001)
Induction of neuronal cell death by Rab5A-dependent endocytosis of α-synuclein
JY Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Clinical phenotype in patients with α-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease
S Papapetropoulos et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and-2
C Knott et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2000)
Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
BI Giasson et al.
SCIENCE (2000)
Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
R Borghi et al.
NEUROSCIENCE LETTERS (2000)
Dityrosine cross-linking promotes formation of stable α-synuclein polymers -: Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies
JM Souza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)